https://sanfrancisco365.info/2025/10/13/merck-commits-nearly-2-billion-to-revolutionary-oral-lipid-lowering-drug-from-chinese-biotech/
Merck commits nearly $2 billion to acquire oral lipid-lowering drug from Chinese biotech firm, aiming to expand its cardiovascular portfolio and enhance global market reach, BioSpace reports.
—-
Author : Miles Cooper
Publish date : 2025-10-13 16:47:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
Merck Commits Nearly $2 Billion to Revolutionary Oral Lipid-Lowering Drug from Chinese Biotech – sanfrancisco365.info
